Kiran Mazumdar-Shaw

Meet Kiran Mazumdar-Shaw

“There currently exists an ugly and unethical divide between the billion who have health security in the developed world and the nearly seven billion others who are vulnerable to disease and death because of little or no access to health protection. Whilst the developed world spends 12 percent of its GDP on healthcare, the developing world spends less than 3 percent. The disease burden is even more skewed. 80 percent of non-communicable diseases are in the developing world, killing 30 million and driving 100 million into poverty every year. These deaths could be prevented if only they had access to essential and life-saving medicines. For the vast majority in the developing world, life is about survival and the pharma and drug development industry needs to throw them a lifeline by developing disruptive new technologies that can bridge the resource deficit.”